Target
Serine/threonine-protein kinase Chk1
Ligand
BDBM401925
Substrate
n/a
Meas. Tech.
Kinase Inhibiting Activity Assay
IC50
0.074±n/a nM
Citation
 Boyle, RGWalker, DWBoyce, RJPeterson, SFarouz, FVo, CH Pharmaceutical compounds US Patent  US10010547 Publication Date 7/3/2018 
Target
Name:
Serine/threonine-protein kinase Chk1
Synonyms:
CHEK1 | CHK1 | CHK1 checkpoint homolog | CHK1_HUMAN | Checkpoint kinase-1 (CHK1)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
54443.02
Organism:
Homo sapiens (Human)
Description:
gi_166295192
Residue:
476
Sequence:
MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASSEENVKYSSSQPEPRTGLSLWDTSPSYIDKLVQGISFSQPTCPDHMLLNSQLLGTPGSSQNPWQRLVKRMTRFFTKLDADKSYQCLKETCEKLGYQWKKSCMNQVTISTTDRRNNKLIFKVNLLEMDDKILVDFRLSKGDGLEFKRHFLKIKGKLIDIVSSQKIWLPAT
  
Inhibitor
Name:
BDBM401925
Synonyms:
5-[[5-[2-methoxy-4-[(3S)-pyrrolidin-3-yl]oxy-phenyl]-1H-pyrazol-3-yl]amino]pyrazine-2-carbonitrilehydrochloride | US10010547, Example 33 | US10973817, Example 33
Type:
Small organic molecule
Emp. Form.:
C19H19N7O2
Mol. Mass.:
377.3999
SMILES:
COc1cc(O[C@H]2CCNC2)ccc1-c1cc(Nc2cnc(cn2)C#N)n[nH]1
Structure:
Search PDB for entries with ligand similarity: